5 Penny Stocks To Buy (September 2024)

Summary

This video discusses the top five penny stocks poised for extreme growth in September 2024, each with potential catalysts like FDA approvals or product launches. The stocks include Red Cat Holdings in the drone sector, ReShape Life Sciences targeting obesity treatment, Lantern Pharma using AI for cancer therapies, Profase Labs with an antiviral drug in trials, and Veritone offering AI solutions across industries. The video emphasizes the importance of trading penny stocks for short-term gains and provides insights into upcoming catalysts that could drive their prices.

Takeaways

• 📈 The video discusses the top five penny stocks with potential for extreme growth in September 2024, each with a clear catalyst for price spikes.
• 🚀 Stocks with high volatility can experience significant price increases followed by sharp declines, which is why timing and trading strategy are crucial.
• 💡 The importance of conducting due diligence on penny stocks is emphasized, as they can be highly speculative and risky investments.
• 🔗 A recommendation is made for a trading platform, Mumu, which is offering up to 30 free stocks for new users, highlighting a special deal for viewers.
• 🔬 Red Cat Holdings (RCAT) is highlighted as a company in the drone and defense sector with potential for growth, focusing on drone hardware, software, and services.
• 🏥 ReShape Life Sciences (RSLS) is targeting the obesity treatment sector with its Lap Band system, aiming to capture a portion of a market projected to reach $27 billion by 2030.
• 🧬 Lantern Pharma (LTRN) uses AI to discover cancer therapies, with its lead compound entering clinical trials, offering a unique approach to drug development.
• 💊 Profase Labs (PRPH) is preparing for the commercialization of its antiviral drug, with final phase trial data expected, which could lead to significant price increases if successful.
• 💡 Veritone Inc. (VERI) is an AI technology company with solutions across media, advertising, government, and other sectors, looking to expand into energy optimization and AI adoption.
• ⏰ Upcoming catalysts for these stocks include new military contracts, regulatory approvals, clinical trial updates, new product launches, and strategic partnerships.

Q & A

What is the main focus of the video?

The main focus of the video is to discuss the top five penny stocks for potential extreme growth in September 2024, highlighting stocks with catalysts such as FDA approval dates, new product launches, or other predetermined events that could lead to significant price spikes.

What is meant by 'catalyst' in the context of the video?

In the context of the video, 'catalyst' refers to events or developments that can trigger a rapid increase in a stock's price, such as FDA approval dates, new product launches, or other significant company announcements.

Why is it suggested not to hold penny stocks for the long term?

It is suggested not to hold penny stocks for the long term because they are volatile and often experience a 'pump and dump' pattern, where the stock price spikes after a catalyst and then drops as investors lock in profits. Long-term holding without reacting to these market movements can lead to significant losses.

What is the significance of the broker recommendation in the video?

The video recommends Mumu as a broker for trading penny stocks, highlighting their offer of up to 30 free stocks to try out their platform. This is presented as a significant deal compared to other brokers and is intended to encourage viewers to consider using Mumu for their trading needs.

What is Red Cat Holdings and why is it highlighted in the video?

Red Cat Holdings is a company in the drone and defense sector, highlighted for its potential growth due to its focus on drone hardware, software, and services. It is seen as an emerging player with solid momentum and strategic partnerships, making it an interesting penny stock for investors looking for potential catalyst-driven growth.

What are the potential catalysts for Red Cat Holdings' stock price?

Potential catalysts for Red Cat Holdings' stock price include new military contracts, expansion into commercial markets, and new product launches. Each of these developments could lead to a significant spike in the stock price.

What is ReShape Life Sciences and how does it relate to penny stocks discussed in the video?

ReShape Life Sciences is a company targeting the obesity treatment sector with its minimally invasive weight loss surgery system. It is related to penny stocks in the video as it is presented as a stock with potential for significant price spikes due to its market segment and upcoming catalysts such as regulatory approvals and new product developments.

How does Lantern Pharma's AI technology contribute to its potential as a penny stock?

Lantern Pharma uses AI to analyze data and discover cancer therapies, which is a unique approach in the biotech sector. Its RADR platform's ability to predict patient responses to drug compounds can significantly speed up drug development, making it an attractive investment for those looking for penny stocks with innovative technology and potential for growth.

What is the significance of Profase Labs' final phase trial data expected in September?

The final phase trial data for Profase Labs' main drug, Equivir, is significant as it could lead to a 'sergy murgy' or a significant price spike if the trial results are positive. This is a key catalyst for the stock, as the success of the trial could pave the way for commercialization and potentially increase the company's revenue and stock value.

What are the key sectors Veritone Inc operates in and how do they contribute to its potential as a penny stock?

Veritone Inc operates in sectors such as media, advertising, government, and energy, offering AI-driven solutions. Its diversification and key partnerships with large corporations and government entities provide steady revenue streams and potential for growth, making it a penny stock with multiple catalysts for price spikes, such as expansion into new sectors and increased AI adoption.

Outlines

00:00

📈 Top 5 Penny Stocks for Growth in September 2024

The video discusses the top five penny stocks with high growth potential in September 2024. These stocks have catalysts such as FDA approval dates or new product launches. The narrator emphasizes the importance of trading the stock movements rather than holding them, citing the example of a previous pick that spiked and then dropped significantly. The video also promotes a broker, Mumu, offering up to 30 free stocks for new users. The first stock discussed is Red Cat Holdings, an emerging player in the drone and defense sector with a focus on drone hardware, software, and services. The company has strategic partnerships that could lead to price spikes, and it is involved with Teal Drones, which produces military-grade drones. Analysts are optimistic about Red Cat's growth, with price targets ranging from $4 to $5 per share. Upcoming catalysts include new military contracts, expansion into commercial markets, and new product launches.

05:02

🏥 Reshaping Life Sciences: Obesity Treatment Innovations

The second paragraph focuses on ReShape Life Sciences, a company targeting the obesity treatment sector with its flagship product, the LAP-BAND adjustable gastric banding system. The company aims to improve the quality of life for those struggling with obesity through minimally invasive weight loss surgery. The global obesity management market is projected to reach $27 billion by 2030, and ReShape is poised to capture a significant portion of this market. The company's stock has shown potential for significant spikes, and upcoming catalysts include expanded commercialization of their LAP-BAND system, regulatory approvals, clinical trials, new product development, strategic partnerships, and positive earnings reports.

10:02

🧬 Lantern Pharma: AI-Driven Cancer Treatments

Lantern Pharma is introduced as a company that combines AI and biotechnology to discover cancer therapies. Its RADR platform analyzes large data sets to identify potential drug candidates. The company's primary market includes oncology professionals, research institutions, and pharmaceutical companies seeking AI-driven insights. Lantern Pharma has a lean business model that allows for faster and lower-cost drug candidate development. The company has four key drug candidates in various stages of development, with LP 1884 being the most notable, targeting multiple solid tumors and moving into clinical trials. Upcoming catalysts for the company include FDA approvals, progress in the FDA pipeline, and potential partnerships that could significantly impact the stock price.

💊 Profase Labs: Antiviral Treatments and Diagnostics

Profase Labs is highlighted for its work on commercializing an antiviral treatment and its involvement in diagnostic testing. The company became a key provider of rapid testing solutions during the COVID-19 pandemic. Its consumer healthcare business offers over-the-counter remedies, and its genomic services focus on personalized medicine and genetic testing. Upcoming catalysts for the stock include the launch of a new over-the-counter antiviral, regulatory approvals, and increased AI adoption in media, which could drive the stock price upwards.

🔍 Veritone Inc: AI Solutions for Diverse Industries

The final paragraph discusses Veritone Inc, an AI technology company offering solutions for media, advertising, government, and other sectors. The company's AI Wear platform provides real-time insights and data analysis for businesses. Veritone has partnerships with large corporations and government entities, providing a steady revenue stream. The company is expanding into the energy sector with AI solutions for optimizing energy grids and predicting demand. Upcoming catalysts include new government contracts, especially in law enforcement and security, and increased AI adoption in media, which could lead to significant stock price spikes.

Keywords

💡Penny Stocks

Penny stocks refer to low-priced, small-cap stocks that are considered highly speculative and carry more risk compared to blue-chip stocks. In the video, the term is used to describe the type of stocks being discussed, which are characterized by their potential for significant price spikes and subsequent drops, often due to market reactions to specific events or catalysts.

💡Catalyst

A catalyst in the context of the video is an event or piece of news that can trigger a significant price movement in a stock. Examples given include FDA approval dates, new product launches, or other predetermined events that can cause a stock's value to spike, as mentioned in relation to the stocks discussed for their potential growth in September 2024.

💡Spikeability

Spikeability refers to the potential of a stock to experience a sudden, sharp increase in price. The video emphasizes that the stocks being discussed have high spikeability, meaning they are capable of massive price increases on certain catalysts, followed by a significant drop as investors lock in profits.

💡FDA Approval

The FDA (Food and Drug Administration) approval is a critical catalyst mentioned in the video for stocks in the healthcare sector. Stocks of companies awaiting FDA approval for their products can experience significant price movements upon receiving the approval, as it can lead to increased market access and revenue potential.

💡Drone Technology

Drone technology is highlighted in the video as a sector with potential for growth, particularly for companies like Red Cat Holdings, which are involved in the development and deployment of drones for various applications, including defense and surveillance. The video suggests that advancements in drone technology can be a catalyst for stock price increases.

💡AI in Biotech

The integration of artificial intelligence (AI) in biotechnology is a theme in the video, exemplified by Lantern Pharma's use of AI to discover cancer therapies. The company's AI platform processes large data sets to identify potential drug candidates, which can be a significant catalyst for the stock if successful in clinical trials or gaining approvals.

💡Pump and Dump

A pump and dump scheme refers to a type of market manipulation where the price of a stock is artificially inflated ('pumped') through misleading statements or false information, only to be sold off ('dumped') by the perpetrators at a higher price before the truth is revealed. The video discusses a 'pump and dump uptrend' in a more neutral sense, referring to the pattern of price increases followed by declines in certain stocks.

💡Regulatory Approvals

Regulatory approvals are mentioned as a catalyst for stock price movements, particularly in the healthcare and pharmaceutical sectors. Obtaining approvals from regulatory bodies like the FDA can validate a company's products and services, leading to increased investor confidence and potential stock price increases.

💡Commercialization

Commercialization in the context of the video refers to the process of bringing a product or service to the market. For stocks like those of Profase Labs, the successful commercialization of their products, such as an antiviral treatment, can be a significant catalyst, potentially leading to increased revenue and stock price growth.

💡AI Adoption

AI adoption refers to the integration and use of artificial intelligence technologies across various industries. The video discusses Veritone Inc., a company that offers AI-driven solutions to different sectors, suggesting that increased adoption of AI in industries like media, government, and energy can serve as a catalyst for the company's stock price.

Highlights

Discussing the top five penny stocks for extreme growth in September 2024.

Each stock has a clear catalyst like an FDA approval date or new product launch.

Penny stocks with huge spike ability that go up massively on catalyst and then dump as people lock in profits.

The opportunity with penny stocks is in the reaction, not endlessly holding and hoping.

Recommendation to use Mumu as a broker for trading penny stocks, offering up to 30 free stocks.

Red Cat Holdings (RCAT) is an emerging player in the drone and defense sector.

Red Cat focuses on providing drone hardware, software, and services for security, surveillance, and remote data collection.

Red Cat's strategic strength lies in its partnerships, providing a rolling round of catalysts.

Red Cat involved with Teal Drones, which produces military-grade drones eligible for government contracts.

Analysts see Red Cat as a stock that could double in value within the next few years.

Upcoming catalysts for RCAT include new military contracts, expansion into commercial markets, and new product launches.

ReShape Life Sciences (RSLS) is targeting the obesity treatment sector with its Lap Band system.

RSLS's system is designed for minimally invasive weight loss surgery.

The global obesity management market is projected to reach $27 billion by 2030.

LTRN Lantern Pharma combines AI with biotech to discover cancer therapies.

Lantern Pharma's RADR platform analyzes data to uncover drug candidates.

Lantern Pharma's lead compound is entering clinical trials.

PRPH Profase Labs is preparing for the commercialization of their main drug Equa with final phase trial data expected.

Profase Labs serves the diagnostic testing industry and the consumer Healthcare Market.

Upcoming catalysts for PRPH include the launch of a new over-the-counter antiviral and regulatory approvals.

VERI Veritone Inc is an AI technology company offering AI-driven solutions for various sectors.

Veritone's AI Wear platform uses AI to provide real-time insights and data analysis for businesses.

Veritone has key partnerships with large corporations and government entities.

Catalysts for VERI include expansion into the energy sector, new government contracts, and increased AI adoption in media.

Transcripts

folks in today's video we are going to

discuss the top five penny stocks for

extreme growth in September 2024 now

each stock on this video has a clear

Catalyst like an FDA approval date new

product launch or otherwise

predetermined date where Spike ability

can occur but folks these are not little

old grandma stocks these are stocks with

huge Spike ability that go up massively

on Catalyst and then do a big dumpy

dumpo as people lock in profits after

said Catalyst for example if you look at

one of our previous penny stock picks

asst we alerted it at $19 on a Sunday

night before Market open and it ran to a

high of

$3.95 a share a few days later that's a

massive run but do you know what

happened in the days afterwards well the

stock got cut in half the opportunity

with penny stocks is in the reaction

playing the reaction not endlessly

holding and hoping penny stock buy and

holding is guaranteed to make you a

millionaire but only if you start from

billionaire status so if you don't want

to lose money you want to focus on

trading the moves not letting the moves

trade you anyways with that out of the

way make sure that you do your own due

diligence on all ideas presented here on

the channel and we're going to get right

to work also quick plug if you're

wondering what broker to trade these

stocks on today well we highly recommend

you give Mumu a look and they are

offering up to 30 yes up to 30 free

stocks just to try them out in all my

years on YouTube I've never seen a

broker offer this kind of deal so make

sure to check them out if you haven't

already link down below I'm 100% sure

you're going to like them a lot okay now

let's go ahead and get to work so we're

going to start with number one rat rcat

Red Cat Holdings this is an emerging

player in the Drone and defense sector

and it has been seen pretty solid

healthy momentum as they've been

consistently getting big money attention

this year the global drone Market has

expected to grow quite dramatically so

that's probably why many folks are

taking interest in the stock right now

the company focuses on providing drone

Hardware software and services that are

integral to security surveillance and

remote data collection and red cat is

attacking both the governmental and the

private sector Market they specialize in

advanced unmanned aerial systems AKA uas

and related software platforms that

offer real-time data and insights their

Solutions aimed to improve situational

awareness and operational efficiency in

various Fields including defense law

enforcement and infrastructure

inspections now one of red cat strategic

strengths lies in its Partnerships and

these Partnerships provide a rolling

round of catalysts every time a new PR

piece comes out for one of these

Partnerships stalk can go spiky spiko

the company is heavily involved with

teal drones which produces

military-grade drones that are eligible

for government contracts and teal is

listed on the blue uas cleared list

which means it's been cleared by the

Department of Defense for military use

very very big deal now Red Cat holds

several competitive advantages over its

competition for starters it's in-house

expertise in drone manufacturing and

software through its subsidiaries the

company is very vertically integrated

allowing it to offer both hardware and

software Solutions tailored to its

clients needs it's also got cuttingedge

technology the company specializes in

drones that can operate in complex

environments such as underground or in

GPS denied zones a feature that's very

very useful especially for the military

in terms of analyst on the price Target

it's there while analyst opinions on red

cat reflect optimism some analysts see

red cat as a stock that could double in

value within the next few years

especially as Government contracts

continue to roll in current price

targets for arat range from $4 to $5 per

share with potential for significant

upside if the company secures larger

contracts or increases its commercial

presence what about some upcoming

Catalyst that can cause spiky spiko well

number one new military contracts as the

US continues to invest in its military

drone capabilities red cat is well

positioned to benefit from new orders

that any new order could cost a massive

spike in the price number two the

expansion into commercial markets any

new contract there or partnership there

could cause massive spike in the price

and number three new product launches of

course any new and advanced drone could

cause a massive spike in price and

pretty much all year the stock has been

gearing up for what is to come and if

you look at the chart you can see it

follows a pump and dump uptrend which is

one of the best pump and dump Trends you

can get because a pump and dump uptrend

basically means that every low is a

higher low and so the overall uptrend is

nice you can get in during the dump

phase and then ride the moment back up

at the same time being bailed out by the

overall upward Trend if you get out too

late although again remember we like

playing the moves but not letting the

moves play us so that's a last case last

ditch scenario you can see that arcat

has big waves upward as arcat reacts to

a nice Catalyst and then a dump to a

higher low and then another wave upward

and then rinsing and repeating right now

we are at an attempt to recover from the

current dump and we are primed for a

higher breakout sooner or later should

history repeat itself okay number two

rsls reshape life sciences ink which is

targeting the very large obesity

treatment sector no pun intended but

sadly it is very very large it's a very

large segment and it's growing massively

their Flagship product the lap band

adjustable gastric banding system is

designed for minimally invasive weight

loss surgery the company's Mission

centers around improving the quality of

life for people struggling with obesity

by offering Advanced Surgical Solutions

this system is targeting individuals who

are battling obesity but also want a

less invasive way to lose the weight

something better than a gastric bypass

the global obesity management Market is

projected to reach $27 billion by 2030

and reshape is positioned to capture a

meaningful portion of this and as the

rolling Catalyst in PR and update come

out for rsls you should see regular

waves of spiky spiky which for those who

don't speak Spanish are just simple

spikes surges in the share price now if

you look at RS ls's past obviously

horrible one for folks that are buying

holding however it has these waves that

can sometimes as much as 5x the stock

price in smaller case scenarios

sometimes 2x so now with the stock

trading it's 52 we lows it's Prime to

set up for another wave upward if the

right Catalyst comes along so what could

that Catalyst look like exactly Charlie

charito well expanded commercialization

of their lap band system is an obvious

Catalyst there's also the case for

regulatory approvals clinical trial and

new product development strategic

Partnerships obviously positive earnings

reports and so on and so forth all

potential Catalyst for this stock okay

number three ltrn Lantern Pharma this

company combines AI with biotech to

discover cancer Therapies the company's

radr platform analyzes massive data sets

to uncover drug candidates and its lead

compound is entering clinical trials

right now the company's primary Market

includes oncology professionals research

institutions and pharmaceutical

companies seeking AI driven insights to

improve cancer treatment outcomes

Lantern Pharma AI is designed to Target

multiple cancer types including prostate

cancer gleo blastoma ovarian cancer and

others now this radr platform is very

very unique you see by processing

billions of data points a RDR can

predict how patients will respond to

specific drug compounds offering a very

significant advantage in drug

development the company also has a very

lean business model which we like to see

it's not super topheavy either this

allows it to develop drug candidates

faster in with lower costs Lantern Farm

is potential lies in the pipeline of

four key drug candidates currently in

various stages of development the most

notable candidate LP 1884 is targeted at

multiple solid tumors and is currently

moving into clinical trials after

receiving FDA approval for phase one

studies if success this candidate alone

could generate significant revenue for

the company and and contribute to a nice

spiky spiko in terms of other upcoming

catalysts well you got other FDA

approvals any further approvals or

progress in the FDA pipeline related to

their drug candidates can serve as

significant price Catalyst and of course

you do have that partnership Catalyst

which means that any new collaborations

especially with large institutions and

esteemed research institutions

specifically well those could cause a

massive spiky spiko in price or a sergy

mix sergy for folks in Ireland let sery

blue for folks in France okay number

four prph for profase laps this one is

preparing for the commercialization of

their main drug equ a key antiviral with

Final Phase trial data expected in

September so this month now folks if

everything goes well with this final

stage of the trial I'd expect a massive

sergy MC surgy in the price here what

exactly is prph though Charlie Charlie

to well proas serves two primary market

segments the diagnostic testing industry

and the consumer Healthcare Market it

entered the Diagnostics market during

the 2020 p mic and quickly became a key

provider of Rapid testing Solutions with

Diagnostics its main clients include

Healthcare Providers Physicians and

patients who require rapid testing for

respiratory diseases like the 2020

disease the flu and the RSV the

company's consumer Healthcare business

targets a wide range of customers who

purchase OTC remedies like cold EZ for

symptom relief additionally proasis

genomic Services Target both healthc

Care Professionals and researchers with

an increasing focus on personalized

medicine and genetic testing okay that's

great but what about upcoming catalysts

what could cause the stock to do the

holy the holy sergy murgy well several

upcoming catalysts could again firstly

the company is preparing for its launch

of air a new over-the-counter antiviral

that could be a GameChanger in the

treatment of respiratory viruses and

even if it's not a game changer who

cares as long as the stock does it's

sergy murgy it doesn't really matter if

it's a game changer obviously from a

humanitarian standpoint we want it to be

a game changer but from a Trader

standpoint we just need people to be

pumped we need them to be hyped we need

them to love the stock and quite frankly

if aquiver goes on the market and it's

covered across the financial media well

that's all you need additionally there

are some other regulatory approvals that

profase is waiting for and those could

cause spiky spiky toes as well okay

number five the last one today is V for

veritone veritone Inc is a prominent AI

technology company that offers AI driven

solutions for media advertising

government and other sectors the company

has been a key player in the AI sector

particularly with its innovative AI wear

platform which uses AI to provide

real-time insights and data analysis for

businesses this makes veritone

attractive attrac EVO to a variety of

industries from media production to law

enforcement and energy if you look at

some of their key clients here and their

target markets they got media and

entertainment legal in compliance and

energy that's a pretty nice

diversification in terms of industries

of clients veriton has key Partnerships

with large corporations including

commulist media intercom and CBS radio

as well as Government entities these

relationships have given the company

pretty damn steady revenue streams and

the potential for further growth

particular as AI becomes more ingrained

in these industries the company's

expansion into the energy Market with AI

Solutions aimed at optimizing energy

grids and predicting energy demand is a

major growth Avenue additionally veron's

government contracts particularly those

involving law enforcement and National

Security provide again a very very

steady Revenue base okay but what are

some Catalyst for the stock Charlie

charito who's just looking for rally

rally toes well I found three here for

you today number one the expansion into

the energy sector is a big stinking

Catalyst veron's AI solutions for energy

optimization could become a major growth

driver as demand for clean energy and

grid efficiency increases obviously

depending on who wins the election this

could be more or less relevant but quite

frankly I mean I think that youall want

to pay attention to the energy sector

Catalyst on this stock in terms of new

government contracts any new contracts

from federal state or local governments

especially in law enforcement and

security could be significant price

drivers for the stock you also have

increased AI adoption in media obviously

earlier this last year everybody was

talking up AI stocks any stock with

major AI exposure was something that you

should buy according to the financial

media according to institutional flows

as well so quite frankly when you get

another wave of that I believe that

veritone is going to benefit quite a lot

and I believe we're going to get our

nice sergy murgy any of these catalysts

that I just mentioned could provide a

pretty nice Spike and varies overall

pump and dump uptrend anyways folks that

caps off today's video make sure to hit

that ravishing like button and subscribe

make sure to get your up to 30 free

stocks with Mumu using our link down

below and we will see you in the next

video